Third View Private Wealth, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Third View Private Wealth, LLC
- $743 Billion
- Q4 2025
A detailed history of Third View Private Wealth, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Third View Private Wealth, LLC holds 7,149 shares of REGN stock, worth $4.96 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
7,149Holding current value
$4.96 Million% of portfolio
0.74%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
86.4MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...